Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells (Q40088575)
scientific article published on September 2007
Language:
(P31) (Q13442814)
(P50) (Q17418245)
(P304) 4458-4466
(P407) (Q1860)
(P433) 33
(P478) 13
(P577) Saturday, September 1, 2007
(P921) (Q124292)
(Q1281020)
(P1433) (Q15708885)
(P1476) "Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells" (language: en)
(P2093) Viola Baradari
Michael Höpfner
Alexander Huether
Hans Scherübl
(P2860) (Q40246733)
(Q40198503)
(Q39769976)
(Q33990595)
(Q40383741)
(Q40399017)
(Q33863049)
(Q34426444)
(Q33985725)
(Q33860585)
(Q33210740)
(Q40497496)
(Q35923099)
(Q40524806)
(Q35802314)
(Q40550020)
(Q24799372)
(Q28254267)
(Q30433197)
(Q40590583)
(Q40617392)
(Q40623032)
(Q40629817)
(Q35189383)
(Q33965702)
(Q35100487)
(Q35063894)
(Q33962674)
(Q34743301)
(Q34570082)
(Q28366247)
(Q34392061)
(Q34336927)
(Q33949931)
(Q35363829)
(Q28142463)
(Q35134137)
(Q33540069)
(Q34331359)
(Q40743083)
(Q41298622)
(Q42163084)
(Q46566506)
(Q46494095)
(Q44826959)
(Q44542336)
(Q44534289)
(Q44326399)
(Q44295660)
(Q44257942)
(Q44239202)
(Q44086974)
(Q43878365)
(Q43642290)
(Q43590541)
(Q43579769)
(Q54082935)
(Q46235693)
(Q82195092)
(Q69398619)
(Q73209407)
other details
description scientific article published on September 2007

External Links